Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156

CAS  PubMed  Article  Google Scholar 

Salaffi F, Di Carlo M, Farah S, Di Donato E, Carotti M (2019) Prevalence of frailty and its associated factors in patients with rheumatoid arthritis: a cross-sectional analysis. Clin Rheumatol 38:1823–1830

PubMed  Article  Google Scholar 

Haider S, Grabovac I, Berner C et al (2019) Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study. Clin Exp Rheumatol 37:585–592

PubMed  Google Scholar 

Salaffi F, Di Carlo M, Carotti M, Farah S, Giovagnoni A (2020) Frailty prevalence according to the Survey of Health, Ageing and Retirement in Europe-Frailty Instrument (SHARE-FI) definition, and its variables associated, in patients with symptomatic knee osteoarthritis: findings from a cross-sectional study. Aging Clin Exp Res. https://doi.org/10.1007/s40520-020-01667-0

Article  PubMed  PubMed Central  Google Scholar 

Salaffi F, Farah S, Di Carlo M (2020) Frailty syndrome in rheumatoid arthritis and symptomatic osteoarthritis: an emerging concept in rheumatology. Acta Biomed 91:274–296

PubMed  PubMed Central  Google Scholar 

Hippisley-Cox J, Coupland C (2017) Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study. BMJ 358:j4208

PubMed  PubMed Central  Article  Google Scholar 

Auyeung TW, Lee JS, Kwok T et al (2011) Physical frailty predicts future cognitive decline: a four-year prospective study in 2737 cognitively normal older adults. J Nutr Health Aging 15:690–694

CAS  PubMed  Article  Google Scholar 

Santos-Eggimann B, Cuénoud P, Spagnoli J, Junod J (2009) Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci 64:675–681

PubMed  Article  Google Scholar 

Moorhouse P, Rockwood K (2012) Frailty and its quantitative clinical evaluation. J R Coll Physicians Edinb 42:333–340

CAS  PubMed  Article  Google Scholar 

Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381:752–762

PubMed  Article  Google Scholar 

Muscedere J, Waters B, Varambally A et al (2017) The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive Care Med 43:1105–1122

PubMed  PubMed Central  Article  Google Scholar 

Rockwood K, Mitnitski A (2011) Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 27:17–26

PubMed  Article  Google Scholar 

Mitnitski A, Fallah N, Rockwood MR et al (2011) Transitions in cognitive status in relation to frailty in older adults: a comparison of three frailty measures. J Nutr Health Aging 15:863–867

CAS  PubMed  Article  Google Scholar 

Collard RM, Boter H, Schoevers RA, Oude Voshaar RC (2012) Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 60:1487–1492

PubMed  Article  Google Scholar 

Canadian Study of Health and Aging Working Group (2019) Disability and frailty among elderly Canadians: a comparison of six surveys. Int Psychogeriatr 13(Suppl 1):159–166

O’Caoimh R, Galluzzo L, Rodríguez-Laso Á et al (2018) Prevalence of frailty at population level in European ADVANTAGE Joint Action Member States: a systematic review and meta-analysis. Ann Ist Super Sanita 54:226–238

PubMed  Google Scholar 

Mulasso A, Roppolo M, Giannotta F, Rabaglietti E (2016) Associations of frailty and psychosocial factors with autonomy in daily activities: a cross-sectional study in Italian community-dwelling older adults. Clin Interv Aging 11:37–45

PubMed  PubMed Central  Google Scholar 

Beaudart C, Rizzoli R, Bruyere O, Reginster JY, Biver E (2014) Sarcopenia: burden and challenges for public health. 2014 Archives of Public Health Arch Public Heal 72 45

Rizzoli R, Reginster JY, Arnal JF et al (2013) Quality of life in sarcopenia and frailty. Calcif Tissue Int 93:101–120

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis. Report of the european working group on Sarcopenia in older People A. J. Cruz-Gentoft et al. Age and Ageing 39:412–423

Beaudart C, Zaaria M, Pasleau F et al (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 12:e0169548

PubMed  PubMed Central  Article  CAS  Google Scholar 

Cruz-Jentoft AJ, Romero-Yuste S, Chamizo Carmona E, Nolla JM (2021) Sarcopenia, immune-mediated rheumatic diseases, and nutritional interventions. Aging Clin Exp Res. https://doi.org/10.1007/s40520-021-01800-7

Article  PubMed  PubMed Central  Google Scholar 

Cesari M, Penninx BW, Pahor M et al (2004) Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 59:242–248

PubMed  Article  Google Scholar 

Schaap LA, Pluijm SM, Deeg DJ, Visser M (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 119:526.e9–17

Article  CAS  Google Scholar 

Visser M, Pahor M, Taaffe DR et al (2002) Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the health ABC study. J Gerontol A Biol Sci Med Sci 57:M326–M332

PubMed  Article  Google Scholar 

Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ (1999) Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 107:123–136

CAS  PubMed  Article  Google Scholar 

Breitling LP, Saum KU, Perna L, Schöttker B, Holleczek B, Brenner H. Frailty is associated with the epigenetic clock but not with telomere length in a German cohort. Clin Epigenetics 8:21

Van Epps P, Oswald D, Higgins PA et al (2016) Frailty has a stronger association with inflammation than age in older veterans. Immun Ageing 13:27

PubMed  PubMed Central  Article  Google Scholar 

Franceschi C, Bonafè M, Valensin S et al (2000) Inflammaging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244–254

CAS  PubMed  Article  Google Scholar 

Saum KU, Dieffenbach AK, Jansen EH et al (2015) Association between oxidative stress and frailty in an elderly German population: results from the ESTHER Cohort Study. Gerontology 61:407–415

CAS  PubMed  Article  Google Scholar 

Leng SX, Tian X, Matteini A et al (2011) IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age Ageing 40:475–481

PubMed  PubMed Central  Article  Google Scholar 

Walston J, McBurnie MA, Newman A et al (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162:2333–2341

PubMed  Article  Google Scholar 

Puts MT, Visser M, Twisk JW, Deeg DJ, Lips P (2005) Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol (Oxf) 63:403–411

CAS  Article  Google Scholar 

Dutra MT, Avelar BP, Souza VC et al (2015) Relationship between sarcopenic obesityrelated phenotypes and inflammatory markers in postmenopausal women. Clin Physiol Funct Imaging 37:205–210

PubMed  Article  CAS  Google Scholar 

Kotler DP (2000) Cachexia. Ann Intern Med 133:622–634

CAS  PubMed  Article  Google Scholar 

Barzilay JI, Blaum C, Moore T et al (2007) Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 167:635–641

PubMed  Article  Google Scholar 

Mochizuki T, Yano K, Ikari K, Okazaki K (2019) Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: a cross-sectional study. Geriatr Gerontol Int 19:907–912

PubMed  Article  Google Scholar 

Munro R, Capell H (1997) Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann Rheum Dis 56:326–329

CAS  PubMed  PubMed Central  Article  Google Scholar 

Schaper F, Rose-John S (2015) Interleukin-6: biology, signaling and strategies of blockade. Cytokine Growth Factor Rev 26:475–487

CAS  PubMed  Article  Google Scholar 

Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB (1995) Interleukin-6 levels in the blood do not correlate with bone density in postmenopausal women. J Am Geriatr Soc 43:236–239

CAS  PubMed  Article  Google Scholar 

Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245–270

CAS  PubMed  Article  Google Scholar 

de Gonzalo-Calvo D, Neitzert K, Fernandez M et al (2010) TNF-alpha and IL-6 as potential biomarkers of different inflammatory responses in aging and disease. Free Radic Biol Med 49:733–737

Schaap LA, Pluijm SM, Deeg DJ et al (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 64:1183–1189

PubMed  Article  CAS  Google Scholar 

Reid MB, Li YP (2011) A cellular viewpoint on tumor necrosis factor-alpha and muscle wasting. Respiration Research 2:269–272

Article  Google Scholar 

Wang DT, Yin Y, Yang Y et al (2014) Resveratrol prevents TNF-alpha-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes. Int Immunopharmacol 19:206–213

CAS  PubMed  Article